It is demonstrated that the most commonly used clinicopathological factors used to provide important prognostic information for monitoring disease progression in PCa are serum prostate-specific antigen (PSA) level, the Gleason score, the pathological tumor stage, and the surgical margin (Quinn et al., 2001). This evidence concerns the gene KLK3 and posterior cortical atrophy.